Event Title

Session 2I: Examining TGR as a Drug Target against Human Schistosomiasis

Session Number

Session 2I: 2nd Presentation

Advisor(s)

Dr. David Williams, Rush University

Location

Room A119

Start Date

26-4-2018 10:35 AM

End Date

26-4-2018 11:20 AM

Abstract

Schistosomiasis is a waterborne, parasitic disease often found in underdeveloped areas in Africa, Southeast Asia, and South America that affects 260 million people worldwide. Currently, there is only one drug used to treat schistosomiasis, Praziquantel. However, scientists believe the worm may soon evolve resistance to the drug, as proven in a laboratory environment, stressing the need for another form of treatment.

Share

COinS
 
Apr 26th, 10:35 AM Apr 26th, 11:20 AM

Session 2I: Examining TGR as a Drug Target against Human Schistosomiasis

Room A119

Schistosomiasis is a waterborne, parasitic disease often found in underdeveloped areas in Africa, Southeast Asia, and South America that affects 260 million people worldwide. Currently, there is only one drug used to treat schistosomiasis, Praziquantel. However, scientists believe the worm may soon evolve resistance to the drug, as proven in a laboratory environment, stressing the need for another form of treatment.